|
US4659715A
(en)
|
1986-03-07 |
1987-04-21 |
Louisiana State University And Agricultural And Mechanical College |
Method of inhibiting body fat stores
|
|
US4783469A
(en)
|
1986-03-07 |
1988-11-08 |
Meier Albert H |
Method of inhibiting body fat stores
|
|
US4791125A
(en)
|
1987-12-02 |
1988-12-13 |
Pfizer Inc. |
Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
|
|
US5700800A
(en)
|
1988-05-10 |
1997-12-23 |
Ergo Science Incorporated |
Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
|
|
US5744477A
(en)
|
1988-05-10 |
1998-04-28 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Method for treatment of obesity using prolactin modulators and diet
|
|
US6004972A
(en)
|
1988-05-10 |
1999-12-21 |
The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College |
Therapeutic process for the treatment of the pathologies of type II diabetes
|
|
US5731287A
(en)
|
1988-05-10 |
1998-03-24 |
Louisiana State University And Agricultural And Mechanical College |
Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
|
|
US5344832A
(en)
|
1990-01-10 |
1994-09-06 |
The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College |
Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
|
|
US5585347A
(en)
|
1988-05-10 |
1996-12-17 |
Ergo Science Incorporated |
Methods for the determination and adjustment of prolactin daily rhythms
|
|
US5668155A
(en)
|
1988-05-10 |
1997-09-16 |
The General Hospital Corporation |
Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
|
|
US5468755A
(en)
|
1988-05-10 |
1995-11-21 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Therapeutic process for the treatment of the pathologies of Type II diabetes
|
|
US5830895A
(en)
|
1988-05-10 |
1998-11-03 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Methods for the determination and adjustment of prolactin daily rhythms
|
|
US5006526A
(en)
|
1988-10-17 |
1991-04-09 |
Louisiana State University |
Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
|
|
IT1235053B
(it)
*
|
1989-04-07 |
1992-06-17 |
Poli Ind Chimica Spa |
Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti.
|
|
CA2030174C
(en)
|
1990-01-10 |
1996-12-24 |
Anthony H. Cincotta |
Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
|
|
US5696128A
(en)
|
1994-07-07 |
1997-12-09 |
The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College |
Method of regulating immune function
|
|
IL112106A0
(en)
|
1993-12-22 |
1995-03-15 |
Ergo Science Inc |
Accelerated release composition containing bromocriptine
|
|
GB9421836D0
(en)
*
|
1994-10-28 |
1994-12-14 |
Scherer Corp R P |
Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
|
|
US5565454A
(en)
|
1995-05-31 |
1996-10-15 |
Ergo Science, Incorporated |
Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions
|
|
US5626860A
(en)
|
1995-06-07 |
1997-05-06 |
The Board Of Supervisors Of Louisana State And Agricultural And Mechanical College |
Method for regulating metabolism with dopamine beta hydroxylase inhibitors
|
|
US5714519A
(en)
|
1995-06-07 |
1998-02-03 |
Ergo Science Incorporated |
Method for regulating glucose metabolism
|
|
US5792748A
(en)
|
1995-06-07 |
1998-08-11 |
The General Hospital Corporation |
Method for inhibiting neoplastic disease in mammals
|
|
US20010016582A1
(en)
|
1997-04-28 |
2001-08-23 |
Anthony H. Cincotta |
Method and composition for the treatment of lipid and glucose metabolism disorders
|
|
US5877183A
(en)
|
1996-06-06 |
1999-03-02 |
Ergo Research Corporation |
Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists
|
|
US9655865B2
(en)
|
2002-07-29 |
2017-05-23 |
Veroscience, Llc |
Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes
|
|
US20040077679A1
(en)
|
2002-07-29 |
2004-04-22 |
Cincotta Anthony H. |
Therapeutic treatment for the metabolic syndrome and type 2 diabetes
|
|
US20080200453A1
(en)
|
2002-07-29 |
2008-08-21 |
Cincotta Anthony H |
Methods of treating metabolic syndrome using dopamine receptor agonists
|
|
US20040220190A1
(en)
|
2002-07-29 |
2004-11-04 |
Cincotta Anthony H. |
Methods of treating metabolic syndrome using dopamine receptor agonists
|
|
US20050054652A1
(en)
|
2002-07-29 |
2005-03-10 |
Cincotta Anthony H. |
Methods of treating metabolic syndrome using dopamine receptor agonists
|
|
US20040081678A1
(en)
|
2002-08-09 |
2004-04-29 |
Anthony Cincotta |
Therapeutic process for the treatment of obesity and associated metabolic disorders
|
|
US8821915B2
(en)
|
2002-08-09 |
2014-09-02 |
Veroscience, Llc |
Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
|
|
ES2625429T3
(es)
|
2003-01-23 |
2017-07-19 |
Esperion Therapeutics Inc. |
Compuestos de hidroxilo y composiciones para el control del colesterol y utilizaciones correspondientes
|
|
US7655692B2
(en)
|
2003-06-12 |
2010-02-02 |
Pfizer Inc. |
Process for forming amorphous atorvastatin
|
|
US20050215558A1
(en)
|
2004-03-25 |
2005-09-29 |
Cincotta Anthony H |
Methods of identifying responders to dopamine agonist therapy
|
|
US8137993B2
(en)
|
2004-03-25 |
2012-03-20 |
Veroscience Llc |
Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
|
|
US8137994B2
(en)
|
2004-03-25 |
2012-03-20 |
Veroscience Llc |
Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
|
|
DE602006006658D1
(de)
|
2005-03-04 |
2009-06-18 |
Nycomed Pharma As |
Verfahren zur herstellung von calciumzusammensetzungen im kontinuierlichen fliessbett
|
|
CN101868239B
(zh)
*
|
2006-01-05 |
2015-06-10 |
伊森舍丽斯有限公司 |
钾atp通道开放剂的盐及其用途
|
|
JP5215172B2
(ja)
*
|
2006-04-13 |
2013-06-19 |
東亜薬品株式会社 |
乾式直打速崩壊性錠剤
|
|
CN101657186B
(zh)
*
|
2007-04-13 |
2012-07-18 |
陶氏环球技术公司 |
剂型用粒状材料
|
|
EP3524248A1
(en)
|
2007-06-21 |
2019-08-14 |
VeroScience LLC |
Method of treating metabolic disorders and depression with dopamine receptor agonists
|
|
US20100035886A1
(en)
|
2007-06-21 |
2010-02-11 |
Veroscience, Llc |
Parenteral formulations of dopamine agonists
|
|
US20210401824A1
(en)
|
2007-06-21 |
2021-12-30 |
Veroscience Llc |
Parenteral Formulations of Dopamine Agonists
|
|
US8741918B2
(en)
*
|
2007-06-21 |
2014-06-03 |
Veroscience Llc |
Parenteral formulations of dopamine agonists
|
|
US7631155B1
(en)
|
2007-06-30 |
2009-12-08 |
Emc Corporation |
Thin provisioning of a file system and an iSCSI LUN through a common mechanism
|
|
CN101820873A
(zh)
*
|
2007-10-11 |
2010-09-01 |
麦仁斯有限公司 |
包含萘醌基化合物的微粉化粒子的药物组合物
|
|
JP5883382B2
(ja)
|
2009-06-05 |
2016-03-15 |
ヴェロサイエンス・エルエルシー |
代謝障害の治療のためのドーパミン作動薬と第一相インスリン分泌促進薬の組合せ
|
|
US9352025B2
(en)
|
2009-06-05 |
2016-05-31 |
Veroscience Llc |
Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
|
|
WO2011156248A2
(en)
|
2010-06-08 |
2011-12-15 |
Veroscience, Llc |
Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes
|
|
MX2013005705A
(es)
|
2010-11-23 |
2013-09-16 |
Veroscience Llc |
Tratamiento terapeutico para sindrome metabolico, diabetes tipo 2, obesidad, o prediabetes.
|
|
US8431155B1
(en)
|
2012-04-30 |
2013-04-30 |
Veroscience Llc |
Bromocriptine formulations
|
|
US20150011554A1
(en)
|
2013-06-13 |
2015-01-08 |
Veroscience Llc |
Compositions and Methods for Treating Metabolic Disorders
|
|
DK3445362T3
(da)
|
2016-04-20 |
2021-10-11 |
Veroscience Llc |
Sammensætning og fremgangsmåde til behandling af stofskiftesygdomme
|
|
US20170340271A1
(en)
|
2016-05-26 |
2017-11-30 |
Veroscience Llc |
Methods for identifying responders to dopaminergic neuronal enhancing therapies for the treatment of elevated heart rate and metabolic or cardiovascular conditions
|
|
WO2019079623A1
(en)
|
2017-10-18 |
2019-04-25 |
Veroscience Llc |
ENHANCED BROMOCRIPTINE FORMULATIONS
|
|
US11607455B2
(en)
|
2019-09-23 |
2023-03-21 |
Veroscience Llc |
Method for inducing tumor regression
|